Sweden's SOBI offers $1.7 bln to buy CTI BioPharma

South Africa News News

Sweden's SOBI offers $1.7 bln to buy CTI BioPharma
South Africa Latest News,South Africa Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Drugmaker Swedish Orphan Biovitrum (SOBI) said on Wednesday it had agreed to make a $1.7 billion cash offer for CTI BioPharma , a U.S. biopharmaceutical company focused on blood related cancers and rare diseases.

SOBI said it would make a tender offer for $9.10 per CTI share, a premium of 89% over Tuesday's closing price of $4.82, to be partly funded via a share issue, sending CTI's stock sharply higher in early U.S. trade.

"Assuming half of the $1.7 billion purchase price equates to a $850 million rights issue, this would equate to 11% of the current equity base," the broker said in a note."We anticipated this reaction, but this cannot stop us from doing what is right for the company," Oelkers said. CTI's VONJO, which treats rare haematological platelet disorders, will add a differentiated therapy to SOBI's existing portfolio, the Swedish group said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Swedish Orphan Biovitrum to acquire CTI BioPharma in a deal valued at $1.7 billionSwedish Orphan Biovitrum to acquire CTI BioPharma in a deal valued at $1.7 billionSwedish Orphan Biovitrum AB on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma Corp. in a deal valued at $1.7...
Read more »

CTI BioPharma soars on deal news, while Upstart and Rivian climb after earningsCTI BioPharma soars on deal news, while Upstart and Rivian climb after earningsCTI Biotech, Upstart, RingCentral, Twilio and H&R Block were among some of Wednesday's biggest moving stocks in premarket trading.
Read more »

Breakingviews - Swedish drugmaker finds alluring poison pillBreakingviews - Swedish drugmaker finds alluring poison pillSweden’s rare disease drug maker is experiencing unfortunate deal side effects. On Wednesday, shares in Swedish Orphan Biovitrum (SOBI) fell 15% after it announced a plan to buy CTI BioPharma , a specialist in rare blood cancers, for $1.7 billion.
Read more »

Baxter to divest biopharma business for $4.25 billionBaxter to divest biopharma business for $4.25 billionBaxter International Inc said on Monday a private-equity group, which includes Warburg Pincus and Advent International, has agreed to buy its biopharma solutions unit for $4.25 billion.
Read more »

Agency warns Sweden may miss CO2 targets with biofuel cutAgency warns Sweden may miss CO2 targets with biofuel cutSweden will struggle to hit its 2030 emissions targets, a government agency warned on Monday, after the country's minority coalition cut the biofuel that must be added to diesel and gasoline.
Read more »

EUR/SEK: Real estate troubles in Sweden to weigh on the Krona – INGEUR/SEK: Real estate troubles in Sweden to weigh on the Krona – INGA Swedish real estate firm's trouble may cause fresh issues for SEK, economists at ING report. Real estate troubles “SBB, one of Sweden’s largest land
Read more »



Render Time: 2025-03-01 02:01:59